Reports by Industry

Healthcare Reports

Healthcare Reports

Global Prior Authorization Software Market Size, Trends & Analysis - Forecasts to 2028 By Deployment Mode (Cloud and On-Premise), By Type of Compatible Software (Patient Intake Software and Revenue Cycle Management Software), By End-User (Healthcare Providers, Health Insurance Companies, and Pharmaceuticals), and By Region (North America, Asia Pacific, and South America, Europe, and the Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

The Global Prior Authorization Software Market is projected to grow at a CAGR of 9.5% from 2023 to 2028. Read More »


January 5 : 2023

Global Implantable Ports Market Size, Trends & Analysis - Forecasts to 2028 By Type (Single-Lumen Implantable Ports, Double-Lumen Implantable Ports), By Application (Chemotherapy, Blood Transfusion, and Intravenous Infusion of Blood Products), By End-User (Hospitals, Clinics, Others), and By Region (North America, Asia Pacific, South America, Europe, and the Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

The Global Implantable Ports Market is expected to grow from USD 615.5 million in 2022 to 1050.6 million by 2028 and is projected to grow at a CAGR of 7.5% from 2022 to 2028. Read More »


January 3 : 2023

Global Cell & Gene Therapy Manufacturing Market Size, Trends & Analysis - Forecasts to 2028 By Type Scope (Cell Therapy- (Allogeneic, Autologous), Gene Therapy – (Viral Vectors, Non-Viral Vectors)), By Scale (R&D Scale Manufacturing, Commercial-Scale Manufacturing), By Workflow (Cell Processing & Banking, Process Development, Fill & Finish Operations, Analytical & Quality Testing, Vector Production, Others), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), Company Market Share Analysis, and Competitor Analysis

The global cell & gene therapy manufacturing market is valued at USD 15.1 billion in 2022 and is projected to grow at a CAGR of 19.6% from 2023 to 2028. Read More »


January 3 : 2023

Global Adeno-associated Virus Vectors (AAVs) Downstream Processing Market Size, Trends & Analysis - Forecasts to 2028 By Product (Chromatography Systems [Affinity Chromatography, Ion Exchange Chromatography, Size Exclusion Chromatography, Others], Filtration Solutions [Depth Filtration Products, Tangential Flow Filtration Systems, Others], Centrifuges, Others), By Product Type (Single-Use, Multi-Use), By Application (Cell & Gene Therapy Development, Vaccine Development, Others), By Workflow (Purification, Polishing, Fill Finish), By End-User (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

The global adeno-associated virus vectors (AAVs) downstream processing market is projected to grow from USD 27.4 billion in 2022 to USD 48.1 billion by 2028 at a CAGR of 15.3% from 2022 to 2028. Read More »


January 3 : 2023

Global Prenatal and Newborn Genetic Testing Market Size, Trends & Analysis - Forecasts to 2027 By Diagnostic (Chorionic Villus Sampling, Amniocentesis, Maternal Serum Screening, Non-invasive Prenatal Testing, PCR, Spectrophotometer, FISH, Array-Comparative Genomic Hybridization), By Disease Type (Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle cell Anaemia), By End-Use (Hospitals, Maternity and Specialty Clinics, Diagnostic Centres), By Region (North America, Asia Pacific, Central, and South America, Europe, and the Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

The Global Prenatal and Newborn Genetic Testing Market is projected to grow from USD 5.2 Billion in 2022 to USD 8.6 Billion in 2027 at a CAGR of 14.5% from 2022 to 2027. Read More »


December 5 : 2022

Global Allogeneic Cell Therapy Market Size, Trends & Analysis - Forecasts to 2027 By Type (T-Cell Therapy, Stem Cell Therapy, Others), By Indication (Cancer, Musculoskeletal Disorders (MSD), Cardiovascular Diseases, Others), By End-User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Research Institutes), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

The global allogeneic cell therapy market is projected to grow from USD 994.9 million in 2022 to USD 1,570.1 million in 2027 at a CAGR of 9.6% from 2022 to 2027. Read More »


August 22 : 2022

Global Mhc Multimers Market Size, Trends & Analysis - Forecasts to 2027 By Product Type (Classical MHC Multimers [MHC class I, MHC class II], Non-Classical MHC Multimers [CD1d]), By Application (Detection of Rare Antigen-specific T Cells, Detection Antigen-specific T Cells, Therapeutic Application [Stem Cell Transplantation Application, Oncology and Infectious Disease Vaccines]), By Target Type (CD8 & CD4 T Cells Target Detection, NKT Cells, T Cells, MAIT Cells Target Detection), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

The global MHC multimers market is projected to grow at a CAGR value of 4.8% from 2022 to 2027. Read More »


August 22 : 2022

Global Oncology Sequencing Market Size, Trends & Analysis - Forecasts to 2027 By Technology (Whole-Genome Sequencing, Exome Sequencing, Targeted Sequencing, RNA Sequencing), By Product (Instruments & Platforms, Reagents & Other Consumables), By Application (Clinical and Research), By Indication (Breast Cancer, Ovarian Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Cervical Cancer, Others), By End-use (Pharmaceutical & Biotechnology Company, Academic & Government Research Institutes, and Others), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

The global oncology sequencing market is projected to grow at a CAGR value of 13.5% from 2022 to 2027. Read More »


August 22 : 2022

Global Clinical Trial Supplies Market Size, Trends & Analysis - Forecasts to 2027 By Clinical Phase (Phase I, Phase II, Phase III, Others), By Service (Manufacturing, Storage & Distribution, Supply Chain Management), By Therapeutic Use (Oncology, Diabetes), By End Use (Pharmaceuticals, CROs), By Region (North America, Asia Pacific, Central, and South America, Europe, and the Middle East and Africa), Competitive Landscape Company Market Share Analysis, and Competitor Analysis

The global clinical trial supplies market is projected to grow from USD 2.1 Billion in 2022 to USD 2.9 Billion in 2027 at a CAGR value of 8.5% from 2022 to 2027. Read More »


August 4 : 2022

Global Biopharmaceutical Stability Testing Market Size, Trends & Analysis - Forecasts to 2027 By Type (Monoclonal Antibodies & Antibody-Drug Conjugates, Recombinant Proteins, Vaccines, Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, CMOs & CROs, Academic & Government Research Institutes), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

The global biopharmaceutical stability testing market is projected to grow from USD 3.2 billion in 2022 to USD 10.8 billion in 2027 at a CAGR of 13.3% from 2022 to 2027. Read More »


August 2 : 2022